ArticleBMC infectious diseases2025

Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study.

Benchen Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.